<h2 dir="ltr">What Are Adenoviral Cloning Vectors?</h2>
 An adenoviral shuttle plasmid (transfer vector) contains a transgene expression cassette flanked by adenoviral genomic sequences that mediate recombination into the full adenoviral backbone genome. This shuttle plasmid is the starting point for constructing any custom recombinant adenovirus. Successful adenoviral studies begin with the appropriate cloning backbone. Choose a vector compatible with your development workflow.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
pShuttle backbone vectors, including pShuttle(+), pShuttle(-), and pShuttle-His variants for gene insertion and adenoviral construct assembly&nbsp;
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Tagged expression vectors such as pShuttle-His-18x and pShuttle-2A-RFP for co-expression and protein labeling studies
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Functional assay and reporter vectors, including pPromoter and pSiShuttle for transcriptional analysis and gene regulation&nbsp;
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Ready-to-use adenoviral DNA for simplified preparation of constructs
</li>
</ul>
<h2 dir="ltr"> How to Choose an Adenoviral Cloning Vector</h2>
 Promoter Selection CMV, EF1&alpha;, and CAG promoter options are available for driving transgene expression &mdash; CMV offers strong, broadly active expression, while EF1&alpha; and CAG can provide more consistent expression in certain cell types. Cloning Method Compatibility Gateway-compatible backbones enable site-specific recombination cloning without restriction enzymes, useful for parallel construct generation. Standard multiple cloning sites (MCS) with conventional restriction sites remain available for traditional cloning workflows. Deletion Configuration E1/E3-deleted Ad5 backbones are the standard configuration &mdash; E1 deletion renders the virus replication-deficient, while E3 deletion provides additional cloning capacity. Downstream Production Pathway The shuttle plasmid recombines into the full adenoviral genome during virus production &mdash; selecting a shuttle vector compatible with your packaging cell line and downstream amplification approach avoids compatibility issues later in the workflow. Reporter/Selection Inclusion Shuttle vectors with fluorescent reporters (GFP) or selection markers built into the cassette simplify confirmation of successful cloning and subsequent virus packaging steps. 
<h2 dir="ltr"> Specifications Context</h2>
 After cloning the transgene into an adenoviral shuttle plasmid, the construct is recombined into the full adenoviral backbone genome in packaging systems or recombination-based workflows, followed by amplification in complementing cell lines to generate recombinant adenoviral stocks. Gateway-compatible shuttle vectors enable transfer of validated entry clones into the adenoviral system without re-cloning. Sequence verification of the shuttle construct by restriction analysis or sequencing is recommended before recombination to ensure construct integrity. Product availability reflects MBP&rsquo;s catalogue as of mid-2026. 
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team </a>at MBP for guidance on shuttle vector selection based on promoter configuration and experimental design requirements.

Cloning Vectors

Selection-Drug Killing Curve

Adenovirus-2-Expression-Protocol

pLuc Vector

Unit Quantity

Vector

Note

Shipping Condition

<h2 dir="ltr">What Are AAV Control &amp; Reporter Constructs?</h2>
 Establishing reliable experimental controls is critical in AAV research because transduction efficiency varies substantially by serotype, cell type, multiplicity of infection (MOI), and batch-to-batch variation in viral preparation quality. Matched AAV control and reporter constructs provide the reference point for interpreting experimental results.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Promoter-Specific Blank Vectors used for baseline control, utilize neuron-specific hSyn promoters and high-purity plasmids&nbsp;
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Serotype-Matched Blank Viruses for precise tissue-targeting validation. Available pre-packaged in serotypes 1 through 11
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Bioluminescent Reporter Systems for sensitive measurement of viral delivery.&nbsp; And gene expression featuring luciferase and SV40-luc markers
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Fluorescent Control Constructs carry circ-GFP, GFP, and CBh-gcGFP, for real-time transduction tracking.
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Circular RNA Control Plasmids for advanced non-coding RNA research.&nbsp;
</li>
<li dir="ltr" style="font-family: arial, helvetica, sans-serif;" aria-level="1">
Cloning-Ready Expression Backbones for selected gene insertion and viral packaging workflows using ampicillin-resistant blank vectors
</li>
</ul>
<h2 dir="ltr"> How to Choose AAV Control &amp; Reporter Constructs </h2>
 Serotype and Backbone Matching The control construct should use the same AAV serotype, ITR configuration, and promoter as the experimental construct, ensuring transduction efficiency differences reflect the transgene rather than vector or serotype variation. Fluorescent Reporter Choice GFP and mCherry reporters allow confirmation of transduction by fluorescence microscopy or flow cytometry, with mCherry offering a red-channel option for multiplexed experiments. Luciferase and Dual-Reporter Options Firefly luciferase provides quantitative bioluminescent transduction confirmation; dual reporter systems (e.g., fluorescent + luciferase) allow both visual and quantitative readouts from the same construct. Empty Vector Baseline An empty AAV vector &mdash; same ITRs, serotype, and promoter, no transgene &mdash; establishes the baseline effect of AAV capsid delivery and innate immune activation, independent of the gene of interest. Batch-to-Batch Variation Controls Because AAV preparation quality can vary between batches, including a transduction-efficiency control (e.g., GFP reporter) alongside each new batch of experimental AAV helps confirm comparable functional titer. 
<h2 dir="ltr"> Specifications Context</h2>
 AAV transduction can activate innate immune sensing pathways and, at high vector doses, induce cellular stress responses independently of the transgene. A matched empty vector or reporter control sharing the same serotype and promoter as the experimental construct helps distinguish vector-related effects from genuine transgene-specific phenotypes. Because AAV infectivity can vary between preparations, reporter-based transduction assessments are commonly used to verify functional performance before experimental studies. For in vivo applications, pilot reporter studies can help confirm tissue targeting and delivery efficiency before larger cohorts are committed. Product availability reflects MBP's catalogue as of mid-2026. 
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team </a>at MBP today to get high-quality control/reporter vectors for your lab.

Control/Reporter

Lentiviral Vector Amplification Protocol

AAV Infection Guideline

AAV Packaging Protocol

Lentivector Packaging Protocol

Lentivirus Infection Protocol

pNV-CMV-circ-GFP Control Vector

Vector Map

System

pPromoter Vector

<h2 dir="ltr">What Are Retroviral Cloning Vectors?</h2>
 The transfer plasmid defines the cargo, promoter, and selection strategy of a retroviral vector system. Selecting the right cloning vector backbone determines transgene expression level, integration stability across cell types, and compatibility with available packaging cell lines. Efficient vector development starts with the right cloning backbone. Choose a retroviral vector that supports your research needs.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li data-section-id="po69uo" data-start="658" data-end="756">Retro-Combo Mix vectors for streamlined retroviral construct assembly and expression workflows</li>
<li data-section-id="5ibmf5" data-start="757" data-end="857">pRetro-E1 and pRetro-E2 plasmid backbones for retroviral vector construction and gene expression</li>
<li data-section-id="1y6pp3s" data-start="858" data-end="961">pRetro-E1-HA and pRetro-E2-His tagged vectors for protein detection and downstream characterization</li>
<li data-section-id="gs2x4g" data-start="962" data-end="1091">Retro-Easy1, Retro-Easy2, Retro-Easy-HA, and Retro-Easy-His systems for flexible construct design and expression optimization</li>
<li data-section-id="fzbhcl" data-start="1092" data-end="1178">Pack-Easy Cells for efficient retroviral packaging and vector production workflows</li>
</ul>
<h2 dir="ltr"> How to Choose a Retroviral Cloning Vector</h2>
&nbsp;
Backbone and Expression Architecture
Retroviral cloning vectors in the Retro-Easy and pRetro-E systems utilize CMV-driven expression cassettes for transgene expression following genomic integration. Backbone configuration influences expression consistency, cloning flexibility, and compatibility with downstream packaging workflows.
Promoter Configuration
CMV-based internal promoters provide strong, constitutive expression across a wide range of mammalian cell types. Expression levels may vary depending on the integration site and chromatin environment following retroviral integration.
Packaging Workflow Compatibility
Retroviral cloning vectors are designed for use in standard replication-incompetent packaging systems, where transfer plasmids are supplied alongside packaging components to generate infectious retroviral particles for transduction of dividing cells.
Selection and Tag Options
Vector variants include antibiotic selection markers and epitope-tagged formats (HA, His) to support downstream detection, purification, or functional validation of expressed proteins.
Insert Size Considerations
Gamma-retroviral transfer vectors generally support moderate-sized inserts suitable for most cDNA and reporter constructs, with efficiency influenced by insert length and sequence composition. 
&nbsp;
<h2 dir="ltr">Specifications Context</h2>
&nbsp;
Retro-Easy and pRetro-E vector systems are based on CMV-driven retroviral transfer backbones designed for stable gene delivery in actively dividing mammalian cells. Following packaging, replication-incompetent retroviral particles mediate genomic integration of the transgene, enabling stable expression across cell divisions. Available formats include untagged, HA-tagged, and His-tagged expression vectors, as well as modular backbone variants for flexible construct design. Pack-Easy Cells provide a dedicated packaging platform for efficient retroviral particle production and consistent vector output. These systems support applications in gene expression analysis, functional studies, and stable cell line generation.
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team</a> at MBP and find the right Retrovirus Cloning Vectors for your lab.

Retrovirus Expression Systems Protocol

pRetro-E1

pRetro-E1-HA

pRetro-E2

pRetro-E2-His

<h2 dir="ltr"> What Are Retroviral Control &amp; Reporter Constructs?</h2>
 Every retroviral over-expression experiment requires a matched set of control constructs to confirm that transduction was successful, the packaging system produced infectious virus at an adequate titer, and the empty vector backbone does not itself alter the measured phenotype. Retroviral control and reporter vectors use the same LTR and backbone configuration as experimental over-expression vectors. Reliable controls and reporters improve confidence in transduction and expression studies. Select the control/reporter system appropriate for your experiment.
&nbsp;
<h2 dir="ltr">What you will find:</h2>
&nbsp;
<ul>
<li data-section-id="w0hi5b" data-start="4179" data-end="4269">Retro-CMV Blank Retroviruses used as baseline controls for retroviral delivery systems</li>
<li data-section-id="ut4vdp" data-start="4270" data-end="4370">Fluorescent Reporter Retroviruses (GFP, RFP) for real-time monitoring of transduction efficiency</li>
<li data-section-id="izipmv" data-start="4371" data-end="4456">Bicistronic GFP Reporter Vectors for co-expression and experimental normalization</li>
<li data-section-id="we28ta" data-start="4457" data-end="4544">Epitope-tagged Control Vectors supporting protein detection and expression analysis</li>
<li data-section-id="47lirb" data-start="4545" data-end="4642">Stop-codon Reporter Plasmids for assessing baseline expression and vector background activity</li>
<li data-section-id="1d2i69z" data-start="4643" data-end="4735">CMV-driven control plasmids used in retroviral expression and stable cell line workflows</li>
</ul>
<h2 dir="ltr"> How to Choose Retroviral Control &amp; Reporter Constructs</h2>
 Empty Vector Backbone Matching The empty vector control must match the experimental vector in backbone, LTR configuration, internal promoter, and selection marker &mdash; for pBABE experiments, pBABE-puro empty is correct; for pLNCX2 experiments, an empty pLNCX2 vector is required. Mismatched controls introduce confounding variables. Transduction Efficiency Verification GFP-expressing retroviral controls (pBABE-GFP, pMSCV-GFP) enable real-time FACS-based quantification before proceeding with experimental constructs &mdash; Adequate efficiency is typically assessed empirically based on cell type and experimental design, ensuring that packaging and infection conditions are suitable for downstream applications. Histochemical Detection Needs pLAPSN, derived from the pLXSN backbone, expresses bacterial alkaline phosphatase (AP), detectable histochemically with substrates such as NBT/BCIP &mdash; useful when fluorescence-based detection is not available or appropriate, particularly in fixed tissue sections. In Vivo Tracking Requirements Retroviral GFP and luciferase reporter cell lines support in vivo tracking of transplanted cells in mouse models, including haematopoietic reconstitution studies and tumour xenograft experiments via bioluminescence imaging. Multiplexing Considerations Retroviral GFP reporters are compatible with red-channel markers (RFP, mCherry, tdTomato) in multiplexed imaging and FACS &mdash; ensure control and experimental constructs use spectrally distinct reporters. 
<h2> Specifications Context</h2>
 Retroviral control and reporter systems using Retro-CMV and pRetroG-CMV vectors deliver CMV-driven expression cassettes packaged as replication-incompetent retroviral particles for transduction of actively dividing mammalian cells. These systems support stable genomic integration of GFP/RFP reporters, HA-tagged constructs, bicistronic IRES-based expression formats, and empty vector controls for baseline comparison and experimental normalization. Following transduction, integrated expression is maintained through cell division under selection or reporter-based enrichment, enabling consistent gene expression analysis, functional studies, and stable cell line generation in retroviral workflows. Product availability reflects MBP's catalogue as of mid-2026. 
&nbsp;
<a href="https://mbpinc.net/contact-us">Contact the expert team </a>at MBP to get advanced retroviral control/reporters for your lab today.

ABM